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Crystal structure of APOBEC3A bound
to single-stranded DNA reveals structural basis
for cytidine deamination and speciﬁcity
Takahide Kouno1, Tania V. Silvas1, Brendan J. Hilbert1, Shivender M.D. Shandilya1, Markus F. Bohn1,w,
Brian A. Kelch1, William E. Royer1, Mohan Somasundaran2, Nese Kurt Yilmaz1, Hiroshi Matsuo3,4
& Celia A. Schiffer1
Nucleic acid editing enzymes are essential components of the immune system that lethally
mutate viral pathogens and somatically mutate immunoglobulins, and contribute to
the diversiﬁcation and lethality of cancers. Among these enzymes are the seven human
APOBEC3 deoxycytidine deaminases, each with unique target sequence speciﬁcity and
subcellular localization. While the enzymology and biological consequences have been
extensively studied, the mechanism by which APOBEC3s recognize and edit DNA remains
elusive. Here we present the crystal structure of a complex of a cytidine deaminase with
ssDNA bound in the active site at 2.2 Å. This structure not only visualizes the active site
poised for catalysis of APOBEC3A, but pinpoints the residues that confer speciﬁcity towards
CC/TC motifs. The APOBEC3A–ssDNA complex deﬁnes the 50–30 directionality and subtle
conformational changes that clench the ssDNA within the binding groove, revealing
the architecture and mechanism of ssDNA recognition that is likely conserved among
all polynucleotide deaminases, thereby opening the door for the design of mechanistic-based
therapeutics.
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A
polipoprotein B messenger RNA-editing enzyme, catalytic
polypeptide-like (APOBEC3) proteins are single-stranded
DNA (ssDNA) deoxycytidine deaminases that are among
some of the fastest evolving proteins in the human genome1.
APOBEC3s catalyse a cytidine (C) to uridine (U) zinc-dependent
deamination reaction2–5. The seven APOBEC3 enzymes are
clustered on chromosome 22 (ref. 6). Although each APOBEC3
has a single catalytic active site, the human genome includes three
single-domain (APOBEC3A, C and H) and four double-domain
(APOBEC3B, D, F and D) enzymes. The double-domain enzymes
consist of a catalytically active C-terminal domain (CTD) and an
inactive pseudo-catalytic N-terminal domain (NTD) that can
bind but not edit nucleic acids. Four of the seven APOBEC
enzymes (APOBEC3D, APOBEC3F, APOBEC3G and
APOBEC3H) have been implicated as HIV-1 host restriction
factors7–13. The APOBEC3 enzymes act on ssDNA to introduce
C-to-U modiﬁcations that create G-to-A point mutations on the
paired strand as the U is read as T during replication. Such
mutations in ssDNA can lead to double-strand breaks that may
result in genomic DNA damage that have been observed in
cancer14–20.
In the last decade, our laboratories21–27 along with others28–42
have solved crystal and nuclear magnetic resonance (NMR)
structures of single domains of human APOBEC3s
(Supplementary Fig. 1). These proteins share the same overall
fold43, deaminate cytosines in ssDNA, but vary in their substrate
speciﬁcity, processivity, catalytic rate and ability to restrict HIV-1.
All APOBEC3 domains contain a HAEx28Cx2-4C zinc binding
motif. The carboxylate group of the catalytic glutamic acid
stabilizes the transition state and proton transfer during catalysis
where a water coordinated by the catalytic zinc is the sole source
of proton for the amino group and N3 atom of cytosine2,44,45.
The speciﬁcity of different APOBECs has been elucidated by
the determination of preferred mutagenic hotspot sequences, 50-
CC/TC-30 for APOBEC3A (studied here)46, 50-TC-30 for
APOBEC3F and 50-CC-30 for APOBEC3G10,47,48. APOBEC3G
deaminates hotspots closer to 50-end more efﬁciently than to 30-
end of ssDNA28,30,32,49, but the underlying mechanism for this
preference is not known. Several alternative ssDNA-binding
models for APOBEC3G-CTD and APOBEC3A have been
proposed21,29,35,36. Most recently, the crystal structure of the
inactive pseuodo-catalytic rhesus macaque APOBEC3G-NTD
(rA3G-NTD) (Supplementary Fig. 1b) in complex with poly-dT
ssDNA has been reported42. However, only one complete
deoxythymidine (dT) was resolved in this structure bound in a
shallow cleft far from the pseudo-catalytic zinc-binding motif.
This complex did not reveal how substrate (dC) or product (dU)
may be accommodated for deamination reaction. The details of
ssDNA-binding and -editing mechanisms, and molecular basis
underlying substrate nucleotide sequence speciﬁcities of
APOBEC3 enzymes still remain elusive.
APOBEC3A (A3A) is a single-domain enzyme with the highest
catalytic activity among the human APOBEC3 proteins50. While
the DNA-editing activity inhibiting the replication of retroelements
is beneﬁcial for genome stability, increased expression or defective
regulation of A3A could lead to mutagenesis of human genome and
contribute to carcinogenesis51. The structure of A3A was initially
determined by NMR35 and some preference for DNA over RNA
was suggested by chemical shift perturbation data36. However,
mutations of residues predicted to be involved in DNA targeting
had variable effects on deamination activity, and the detailed
mechanism by which A3A binds DNA substrate is still elusive35,36.
In this study, we determined the crystal structure of a
ssDNA:deaminase complex, or a polynucleotide substrate bound
at the active site of a catalytic domain APOBEC3 protein.
Previously, we solved the crystal structure of the unliganded
inactived A3A (ref. 26) and determined potent binding afﬁnity to
substrate ssDNA of B60 nM, whereas the product exhibited an
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Figure 1 | Crystal structure of A3A in complex with substrate DNA. (a) A3A structure with a 2Fo Fc electron density map contoured at 1s. The protein
is presented as a green-coloured ribbon diagram and the bound DNA is in stick representation (carbons and phosphates, orange; nitrogens, blue; oxygens,
red). A zinc ion at the active centre is depicted as a magenta-coloured sphere. The side chains of zinc-coordinating residues H70, C101 and C106 are shown
as sticks (carbons, green; nitrogens, blue; oxygen, red; sulfurs, yellow). DNA binding at the active site of A3A is presented in (b) ribbon and (c) surface
representation. (d) Conformational changes of residues R28, H29 and Y132 upon DNA binding are indicated by arrows, with side chains in stick
representation (white and green-coloured carbon for the apo (PDB code 4XXO)26 and DNA-bound forms, respectively). Surface electrostatic potentials of
(e) apo and (f) DNA-bound A3A are coloured red to blue for negative and positive charges, respectively, using a scale of  5 to þ 5 kTe 1.
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order of magnitude lower afﬁnity. Here the crystal structure to
2.2 Å of this variant of A3A in complex with substrate DNA
oligonucleotide containing a single 50-TC-30 deamination target
sequence in a polyT background is presented. The central
nucleotides comprising the 50-TCT-30 motif is well ordered and
bound at the active site, revealing the intermolecular interactions
deﬁning speciﬁcity for the bases at each of these three positions.
The target deoxycytidine (dC0), is bound in a reaction-competent
coordination at the active site. This A3A–ssDNA structure
elucidates the molecular basis of nucleotide preferences in the
substrate motif and provides key insights into the overall
molecular mechanisms of DNA editing by cytidine deaminases.
Results
A3A–ssDNA co-crystal structure. A3A (E72A/C171A)26 was
used for co-crystallization with ssDNA. E72A inactivates the
enzyme permitting the formation of stable complexes and C171A
increases solubility. The crystal structure of A3A (E72A/C171A)
in complex with ssDNA was determined by molecular
replacement at 2.2 Å resolution (Fig. 1a–c; Supplementary
Fig. 2). A 15-mer DNA oligonucleotide that binds
A3A with B60 nM afﬁnity26 with a target deoxycytidine (50-
TTTTTTTCTTTTTTT-30) was co-crystallized with A3A. The
ﬁnal reﬁnement of the structure resulted in R-factor/R-free of
0.177/0.225, respectively (Table 1).
There was a single A3A–ssDNA complex in the asymmetric
unit and crystal contacts with symmetry-related complexes did
not correspond to the zinc-coordinated dimer interface we
observed for the apo A3A crystal structure26. The apo A3A
structure included an excess of zinc (50 mM ZnCl) in the
crystallization condition, while the A3A–ssDNA complex lacked
added zinc, which may have destablized the dimer within this
crystal form. The cooperativity upon DNA binding we observed
in solution and interrogated with site-directed mutagenesis26
implicates A3A capable of binding ssDNA in the dimeric form at
least transiently. Nevertheless, cooperativity does not seem to be
essential as the monomeric form of A3A, with a mutation at
H56A, binds substrate DNA with similar afﬁnity26. Most likely
both monomer and dimer forms of A3A play a role in
recognizing substrates in solution.
The target deoxycytidine (dC0) and ﬂanking deoxythymidines
(dT 1 and dT1), as well as one additional deoxyribose at 50-end
and one phosphate at 30-end, were well ordered in the electron
density (50-sugar-dT 1-dC0-dT1-phosphate-30; Fig. 1a). Of the
nearly 1,280Å2 of surface area on the resolved DNA,B620Å2 is
buried in the interface with A3A. The central cytidine (dC0) and
the preceding thymidine (dT 1) are accommodated in a deep
groove formed by Loops 1,3,5 and 7 of A3A (Fig. 1b;
Supplementary Fig. 1a). The bound DNA adopts an irregular
conformation to encircle the side chain of H29 (Fig. 1c).
Compared to apo A3A, there are conformational changes in the
rotamers of the side chains of R28 and H29 in Loop 1, and Y132
in Loop 7, accompanied by more subtle reorganization of N57–
A72 in loop 3 (Fig. 1d; Supplementary Figs 1 and 3). The rest of
the enzyme including the active site remains essentially
unchanged. The groove signiﬁcantly differs from any of the
previously suggested models for how ssDNA binds to A3s (refs
21,29,35,36) including the recent structure of the pseuodo-
catalytic A3G-NTD in complex with poly-dT ssDNA42. This
conformational change allows the groove to sequester the ssDNA
by forming a more complementary molecular surface, both in
terms of van der Waals packing and electrostatic (electropositive)
nature of the groove (Fig. 1e,f).
Recognition of the targeted cytidine. The deoxycytidine (dC0),
which is the target of deamination reaction, is well coordinated
and buried within the active site of A3A. The cytidine ring is
located directly over the hydroxyl group of the T31 side chain,
which likely hydrogen bonds to the p-orbital cloud of the base
ring and simultaneously coordinates O4 atom of the deoxyribose
(Fig. 2a). Residue Y130 contributes to the dC0 positioning by
forming a T-shaped p–p interaction with the pyrimidine ring.
The hydroxyl group of Y130 further forms a hydrogen bond with
50-phosphate of dC0 (Fig. 2b). The H70 side chain is positioned
over the N1 atom of dC0, capable of potentially forming a p–p
stacking (Fig. 2a). The backbone NH of A71 hydrogen bonds to
O2 of dC0. In addition, the carbonyl oxygen atoms of W98 and
S99 form a bifurcated hydrogen bond to NH2 of the cytosine,
which appears to both support the dC0 positioning and dictate
the speciﬁcity for cytosine over thymine.
As expected for a catalytic A3 domain, electron density that ﬁts
a zinc ion was observed coordinating H70, C101, C106 as well as
additional density that ﬁts a Cl ion, with both assignments
conﬁrmed by anomalous difference calculations. To prevent
catalysis, our A3A construct was inactivated by an E72A
mutation, which left the geometry of the active site intact
(Fig. 2a). Instead of the E72 side chain, we observe electron
density that ﬁts a water molecule. Molecular modelling of E72
into this space shows the side chain would be positioned just
proximal to the deamination target, C4-NH2 moiety, of the
cytosine (Fig. 3) and poised for deamination reaction2. After
catalysis and subsequent release of NH3, this coordination, along
with the interactions with W98 and S99, would be unfavourable
for the product uridine. Overall, multiple interactions of the
substrate cytosine with A3A active site residues ensure the
speciﬁc recognition and geometry required for the deamination
reaction and product release.
Table 1 | Data collection and reﬁnement statistics (molecular
replacement).
A3A/DNA complex
Data collection
Space group I222
Cell dimensions
a, b, c (Å) 56.6, 72.7, 115.0
a, b, g () 90.0, 90.0, 90.0
Resolution (Å) 50.00–2.20 (2.24–2.20)*
Rmerge 9.1 (52.8)
I/sI 27.9 (3.0)
Completeness (%) 98.2 (82.9)
Redundancy 13.1 (8.4)
Reﬁnement
Resolution (Å) 50.00–2.20
No. of reﬂections 11,542
Rwork/Rfree 0.177/0.225
No. of atoms
Protein 1,469
Ligand/ion 71/3
Water 100
B-factors
Protein 35.8
Ligand/ion 50.9/55.1
Water 38.7
r.m.s. deviations
Bond lengths (Å) 0.011
Bond angles () 1.040
*Highest-resolution shell is shown in parenthesis.
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Speciﬁcity for pyrimidines at  1 position. The deoxythymidine
at the 50-side of the target (the  1 position; dT 1) has extensive
van der Waals contacts with three residues from Loop 7 (Y130,
D131 and Y132) and W98 in Loop 5 (Fig. 2c). The Watson–Crick
edge of the thymine base faces these Loop 7 residues, and makes
three hydrogen bonds: O2 atom with Y132 backbone amide, N3
with the D131 side chain carboxylate and O4 with a water
molecule. In addition, the D131 side chain has a salt bridge to the
R189 side chain in helix 6, which stabilizes the overall hydrogen
bonding conﬁguration of Loop 7 to the thymine base. This
coordination appears critical as residue 189 is conserved as a basic
residue (Arg/Lys) only in catalytically active A3 domains
(Supplementary Fig. 1; Supplementary Table 1). At the  1
position, deoxcytidine could form similar, but slightly rearranged,
interactions as the N3 atom lacks the proton to hydrogen bond
with D131. Indeed, although A3A has dual speciﬁcity for 50-TC-30
and 50-CC-30 (ref. 40), there is a preference for thymidine at the
 1 position. However, Loop 7 of A3A, in particular residues
Y130 and D131, would likely preclude a larger purine base from
ﬁtting in this position, thus deﬁning the T/C speciﬁcity of A3A.
The conserved N57 is central to the active site geometry. N57 of
A3A is completely conserved among the catalytically active
APOBEC protein domains, while inactive pseudo-catalytic A3
domains have a conserved glycine (Supplementary Fig. 1;
Supplementary Table 1), and widely conserved among other
cytidine/cytosine deaminases from Escherichia coli through Homo
sapiens52. The structure explains this strong conservation, as N57
of A3A is central in recognizing ssDNA with three key distinct
interactions: The side chain of N57 determines the 50–30
directionality of ssDNA binding by forming a hydrogen bond
to O30 atom of dC0, which helps stabilize the geometry of the
DNA backbone and the sugar in a C20-endo conformation
(Fig. 2b; Supplementary Fig. 4a) and induces a backbone
deformation due to steric hindrance with O50 of the target dC0.
The N57 side chain forms a hydrogen bond with the backbone
NH of T31, positioning the T31 side chain to hydrogen bond to
the p-orbital cloud of the dC0 base ring, thus ensuring the
geometry of the target nucleotide within the active site (Fig. 2a;
Supplementary Fig. 4a). Finally, the N57 side chain packs against
both the deoxyribose ring of dC0, stabilizing the orientation of
sugar plane, and H70, which coordinates zinc. Although RNA
deaminase activity has been reported for A3A53,54, if the sugar
was a ribose a steric clash between the 20-OH and H70 would
occur, therefore requiring a conformational rearrangement for
RNA modiﬁcation. Thus, these three pivotal interactions of N57
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Figure 2 | A3A–ssDNA atomic interactions. Stereo-view of the
interactions between A3A and (a) the target nucleotide base (dC0), (b) the
DNA backbone ﬂanking dC0 (c) nucleotide at  1 position (dT 1).
(d) Interactions between H29 side chain and the substrate DNA. Side
chains of A3A residues (carbons green) and the DNA (carbons and
phosphates orange) are in stick representation, with other atoms coloured
as in Fig. 1b. A zinc ion (Zn) at the active centre, the zinc-liganded chlorine
(Cl) and water molecule (W) are indicated by spheres coloured magenta,
green and red, respectively. Estimated hydrogen bonds and p–orbital
interactions are depicted by dashed lines coloured orange and black,
respectively.
dC0
H70
Y130
W98
S99
A71
Zn W
T31
E72
P100
Figure 3 | Structural model of the A3A catalytically active site. The target
nucleotide base (dC0) bound at the A3A active site where the catalytic E72
side chain was modelled in instead of the alanine at this position in the
crystal structure. Zinc, the coordinated water (W), carbonyl oxygen of dC0
and carboxyl oxygen of E72 side chain were connected by dashed lines in
magenta.
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organize the enzyme substrate complex to be poised for catalytic
turnover.
The three central interactions mediated by N57 are strictly
conserved in the active site geometry of other cytidine
deaminases55–57, where the asparagine side chain (1) hydrogen
bonds to substrate backbone, (2) packs to maintain the sugar
orientation and (3) packs against the zinc-coordinating residue
side chain (Supplementary Fig. 4b–d). The RNA cytidine
deaminases replace the zinc coordinating histidine with a
relatively small amino acid, cysteine, which permits a ribose
ring to ﬁt (Supplementary Fig. 4c,d). This structure explains why
although not located directly at the active site, even conservative
N57Q or N57D mutations severely disrupt deaminase
activity29,52,58, thus our A3A–ssDNA structure reveals the
conservation of N57 to be critical for proper orientation of the
substrate within the active sites of cytindine deaminases.
H29 coordinates the ssDNA binding in the active site. H29 is
the other lynchpin in ssDNA binding to A3A. H29 of A3A cor-
responding to H216 in the catalytic domain of A3G (A3G-CTD),
which when mutated to alanine abolishes activity21. Maximal
catalytic activity occurs at pH 5.5 for both A3G-CTD59 and
A3A51, implying that the histidine is protonated. Interestingly,
this His is not completely conserved in other A3s, where this
position is sometimes an arginine or asparagine. The H216R
mutation in A3G and H29R in A3A resulted in reduced but still
signiﬁcant catalytic activity41,59. In the apo A3A crystal
structure26, H29 is involved in crystal contacts and rotated
away from the active site (Fig. 1d). In the NMR structure of A3A
the H29, side chain is solvent exposed and the rotamer is not
deﬁned in solution (PDB code 2M65)35. Thus, upon ssDNA
binding, the side chain of H29 selects a rotamer to interact
extensively with the substrate, latching the active site to permit
catalysis. Once catalysis occurs, H29 needs to rotate out of this
position to release the deaminated product. H29 forms hydrogen
bonds to the backbone phosphates of dT 1, dC0, and dT1, and
the deoxyribose of dT1 (Figs 1d–f and 2d). The side chain of H29
is crucial in dT1 recognition, with the imidazole ring positioned to
form p–p interactions with the pyrimidine ring of dT1. This
relatively non-speciﬁc stacking interaction explains the apparent
lack of speciﬁcity at the þ 1 position. Thus, our structure reveals
the unique role of H29 in positioning the substrate ssDNA with a
series of coordinated hydrogen bonds and stacking interactions,
essentially latching the ssDNA and the target dC0 within the
active site.
A3A and rA3G-NTD differ in DNA binding. The recent
structure of ssDNA bound to the inactive pseudo-catalytic
domain rA3G-NTD42 is not that of a substrate complex and
displays a binding mode that is incompatible with catalysis. In
contrast to our structure, the single base ordered in that structure
is not coordinated within the binding pocket (Supplementary
Fig. 5), but rather a sugar is partially buried in the pocket. More
speciﬁcally, comparing the A3A–ssDNA with the rA3G-NTD–
ssDNA structure: H70, W98, S99 and Y130 in A3A (H65, W94,
S95 and Y125 in rA3G-NTD) are conserved in the two protein’s
sequences and interact with ssDNA; however, there are no
similarities in their interactions with the ssDNA (Figs 2a and 4;
Supplementary Fig. 5). H70 of A3A forms a p-hydrogen bond
with dC0, while H65 of rA3G-NTD forms a hydrogen bond with
C30-carbonyl group of the ribose of dT0. W98 and S99 of A3A use
their backbone carbonyl group to hydrogen bond with amino
group of the target cytidine (dC0), while W94 of rA3G-NTD is
stacking with the pyrimidine of dT0. Y130 of A3A forms a p–p
interaction with dC0 and a hydrogen bond with the phosphate
between dC0 and dT 1, while Y125 of rA3G-NTD forms a
hydrogen bond with C30-carbonyl group of the ribose of dT1.
Many of these interactions preclude the interactions observed in
A3A–ssDNA (Figs 1 and 2). Amino acids with more extensive
interactions with substrate ssDNA are not conserved in sequence
or structure including: H29, which is D, T31, which is V, and the
critical N57, which is G (Supplementary Fig. 1). In addition,
interactions at  1 and þ 1 positions are not observed in the
rA3G-NTD–ssDNA complex structure as only a single dT0 is
ordered in the electron density. Critically, the target cytidine
(dC0) in the A3A is located ready for deamination, while non-
substrate dT0 in the rA3G-NTD is not located close to the
catalytic Zn2þ . This binding mode corresponds to a much lower
afﬁnity of the pseudo-catalytic rA3G-NTD to ssDNA
(B1.6 mM)42 conﬁrming non-speciﬁc binding, compared to
B60 nM (ref. 26) we observed for substrate ssDNA binding to
A3A. While the rA3G-NTD-dT structure may represent
mechanisms by which non-substrate ssDNA binds A3 domains,
the A3A–ssDNA structure we present here elucidates the
mechanism by which ssDNAs are recognized as substrates by
catalytically active A3s.
Molecular recognition in polynucleotide deaminases. Our
crystal structure of the A3A–ssDNA complex and the crystal
structure of Staphylococcus aureus tRNA adenosine deaminase
(TadA) in complex with RNA (2B3J)60 are structures of single-
stranded polynucleotide deaminases bound to their substrates.
Although their substrates are different, as TadA deaminates
adenosine at the anti-codon stem-loop of tRNAArg2 and A3A
deaminates cytosines in ssDNA, their active sites are similar in
that both have a HAExB30Cx2-4C zinc-binding motif. We observe
the most striking similarity in the phosphate-sugar backbone
traces of RNA (TadA) and ssDNA (A3A) (Fig. 4): 50–30
directionality is the same, and the polynucleotide is sharply
bent with the target nucleotide deep in the active site pocket. Five
nucleotides located in the anti-codon stem-loop of tRNAArg2
have adopted C20-endo ribose conformation that is typical for
DNA, explaining how the RNA forms a similar backbone
conformation to the ssDNA bound to A3A (Fig. 4a,d,g). This
remarkable similarity of the phosphate-sugar backbone, despite
different substrates, tRNA for TadA and ssDNA for A3A, implies
that the HAExB30Cx2-4C type zinc-dependent deaminases have an
evolutionary conserved substrate-binding topology as well as
catalytic mechanism.
This crystal structure of an ssDNA substrate–enzyme complex
reveals how substrate recognition occurs by single-stranded
polynucleotide-modifying enzymes, for APOBEC family mem-
bers and other ssDNA deaminases. This is in contrast with the
pseudo-catalytic domain A3G-NTD42, which is not a substrate
complex and has a single base ordered in the structure that is only
partially buried in the binding pocket, displaying a very dissimilar
binding mode (Fig. 4c,f,i). The striking similarity of A3A–ssDNA
(Fig. 4a,d,g) with the structure of TadA–tRNA complex
(Fig. 4b,e,h) implies structural and mechanistic conservation
among single-stranded nucleotide-modifying enzymes that have
evolved to acquire distinct speciﬁcities. These speciﬁcities may be
leveraged for speciﬁc gene editing. APOBEC1 and other cytidine
deaminases were recently combined with CRISPR/Cas9
technology in direct ‘base editing’ to correct point mutations,
without the need for a donor template or double-stranded DNA
breaks61. By leveraging the directionality, speciﬁcity and binding
architecture of ssDNA revealed by our A3A–ssDNA complex,
base-editing technologies will become even more targeted and
speciﬁc to expand the scope and effectiveness of genome editing.
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Methods
Preparation of protein and DNA. The preparation method of A3A(E72A/C171A)
protein was described previously26 as follows: the protein was expressed in E. coli
strain BL21 DE3 Star (Stratagene) cells with pCold-GST-A3A(E72A/C171A)
vector. Expression was induced with 1mM isopropyl b-D-1-thiogalactopyranoside
at 16 C for 22 h in lysogeny broth medium containing 100 mgml l ampicillin.
Cells were pelleted, resuspended in puriﬁcation buffer (50mM Tris-HCl (pH 8.0),
300mM NaCl and 1mM dithiothreitol) and lysed through sonication. Cellular
debris was separated by centrifugation (45,000g, 30min, 4 C). The protein was
puriﬁed as a GST-fused protein with glutathione-immobilized resin (Clontech).
After digesting with HRV 3C protease, the protein was further puriﬁed with a
size-exclusion column (GE Healthcare) equilibrated with a buffer (10mM Tris-HCl
(pH 8.0), 200mM NaCl and 1mM dithiothreitol). The fraction containing the
monomeric form was collected and concentrated for crystallization. The purity and
integrity of A3A(E72A/C171A) was conﬁrmed by SDS–polyacrylamide gel
electrophoresis. E72A inactivates the enzyme, while C171A (distal the active site)
enhances solubility of the expressed protein.
The DNA oligo, d(TTTTTTTTCTTTTTT), was synthesized (Integrated DNA
Technologies), and mixed with the puriﬁed A3A(E72A/C171A) protein at a molar
ratio of 2:1.
Crystallization and data collection. Crystals of the A3A(E72A/C171A)–DNA
complex were grown by hanging-drop vapour-diffusion method over a reservoir of
100mM MOPS (pH 6.5), 50mM MgCl2, 50mM CaCl2, 23% polyethylene glycol
3,350 and 15% 2-methyl-2,4-pentanediol. Drops were formed by mixing 1 ml of
A3A(E72A/C171A)–DNA solution (B20mgml l of protein concentration) and
1 ml of reservoir solution, with equilibration over the reservoir at 20 C. Micro-
seeding was performed using a cat whisker and larger crystals suitable for X-ray
diffraction were obtained. Crystals were ﬂash-frozen directly in the cryogenic
stream. Diffraction data were collected using an in-house X-ray source MicroMax-
007 HF (Rigaku) with a copper anode at a wavelength of 1.54178Å and a Saturn
944 HG (Rigaku) detector. The space group of the crystals was I222 with unit cell
dimensions of a¼ 56.6 Å, b¼ 72.7 Å, c¼ 115.0 Å (Table 1). The collected inten-
sities were indexed, integrated, corrected for absorption and scaled using HKL2000
(ref. 62).
Structure determination. The protein structure was solved by molecular repla-
cement phasing using a previously determined apo A3A(E72A/C171A) crystal
structure (PDB code 4XXO)26 with the program Phaser63. Model building of the
protein and bound DNA, and reﬁnements were manually performed using the
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Figure 4 | Structure and substrate-binding similarity between A3A and RNA deaminase TadA. (a) A3A structure (green ribbon) bound to substrate
DNA (orange sticks, as in Fig. 1b). Three DNA nucleotides (dT 1, dC0 and dT1) are displayed. A zinc ion at the active centre is coordinated by H70 (helix
a2), C101 and C106 (helix a3). (b) TadA structure60 (PDB code 2B3J) (grey ribbon) bound to substrate RNA (orange sticks). Three RNA nucleotides (rU 1,
Neb0 (nebularine) and rC1) are displayed. Zinc-coordinating residues H53 (helix a2), C83 and C86 (helix a3) are shown in stick representation (carbons,
white; nitrogens, blue; oxygen, red; sulfurs, yellow). (c) rA3G-NTD structure (grey ribbon) bound to ssDNA (orange sticks), only dT0 has the base while the
backbone of dT1 and the sugar of dT0 is mapped. Surface representation of the nucleotide-binding site of (d) A3A, (e) TadA (f) A3G-NTD. Close-up view of
the active site of (g) A3A, (h) TadA and (i) A3G-NTD. The catalytic glutamic acid side chain was modelled in instead of alanine at position 72 in the A3A
crystal structure.
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programs Coot64 and Phenix65,66, respectively. A simulated annealing omit map
was calculated to conﬁrm the ssDNA positioning (Supplementary Fig. 6). The ﬁrst
nine residues and the side chains of residues R10, H11, H16, K30, N42, V46, K47,
Q50, Q58, K60, L62, L63, F66, Y67, D177, E181 and N196 of A3A(E72A/C171A)
were not modelled in due to lack of electron density. Residues N42–T44 and L62–
G65 were somewhat disordered; the occupancy values were set to 0.5 for residues
N42–T44, L62 and G65, and to 0.75 for residues L63 and C64 due to poor electron
density. A density proximal to a zinc ion at the active centre was assigned to
chloride considering the statistics of zinc ligand67, resulting in a good ﬁt without
phase-error signals (Supplementary Fig. 7). The identiﬁcation of the active site zinc
is further supported by the highest peak, 9.5s, in an anomalous difference Fourier
map at this position. A smaller peak at 5.6s in this map is present at the assigned
chloride position. The ﬁnal model was reﬁned to R(work)/R(free) values of 0.177/
0.225 at 2.20Å resolution (Table 1). The quality of the ﬁnal model was assessed by
Molprobity68, which indicated that 96.2% of the residues were in the favoured
dihedral angle conﬁguration and there were no Ramachandran outliers.
Structure analysis. Figures of structure models were generated by Pymol69, which
was also used to model in the catalytic E72 side chain in Figs 3 and 4. The
electrostatic distribution of A3A(E72A/C171A) was calculated and visualized using
PDB2PQR server70 and Pymol with the APBS plugin, where the cysteine was
modelled as thiolate anion (S ) and solutes were excluded. Solvent-accessible and
buried surface area was calculated with PISA71. Local root mean square deviation
between apo and DNA-bound forms of A3A(E72A/C171A) was calculated using
Molmol72. The distance difference matrices between the apo- and DNA-bound
forms of A3A(E72A/C171A) were calculated and visualized using a custom-made
script in MacOS Xcode (https://developer.apple.com/xcode/).
Data availability. Atomic coordinates and structural factors for the reported
crystal structure have been deposited in the Protein Data Bank http://
www.wwpdb.org/ under the accession number 5KEG. The data that support the
ﬁndings of this study are available from the corresponding author upon request.
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